Congenital gonadotropin deficiency in boys: management during childhood

L Adan1, A C Couto-Silva, C Trivin

  • 1Université René Descartes and Pediatric Endocrinology Unit, Fondation-Hópital Saint Joseph, Paris, France.

Insights

Low plasma inhibin B and anti-Müllerian hormone (AMH) levels may signal testicular damage in boys with congenital gonadotropin deficiency (CGD). Testosterone treatment effectively restored normal penis length in all patients studied.

Area of Science:

  • Pediatric Endocrinology
  • Reproductive Medicine
  • Developmental Biology

Background:

  • Congenital gonadotropin deficiency (CGD) affects pubertal development and reproductive health in boys.
  • Assessing testicular function in prepubertal and pubertal boys with CGD is crucial for management.
  • Hormonal markers like inhibin B and anti-Müllerian hormone (AMH) may offer insights into testicular function.

Purpose of the Study:

  • To characterize boys diagnosed with congenital gonadotropin deficiency (CGD).
  • To evaluate the predictive value of plasma inhibin B and AMH for testicular function in these boys.
  • To assess the impact of testosterone treatment on physical development.

Main Methods:

  • A cohort of 19 boys with CGD, including five with Kallmann syndrome, was prospectively followed.
  • Clinical features such as micropenis and delayed puberty were recorded.
  • Hormonal levels (inhibin B, AMH, LH, GnRH) and testicular palpation were assessed.

Main Results:

  • Boys presented with micropenis (before age 14) or delayed puberty (after age 14).
  • Testicular non-palpability was noted in 13 patients.
  • Low plasma inhibin B and AMH were observed in some patients, potentially indicating testicular damage, while testosterone treatment normalized penis length.

Conclusions:

  • Low plasma inhibin B and AMH concentrations may serve as indicators of testicular damage in boys with CGD.
  • Testosterone replacement therapy is effective in achieving normal penile growth in boys with CGD.
Abstract

Related Concept Videos

Infertility in Males01:23

Infertility in Males

Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
Sex-linked Disorders01:43

Sex-linked Disorders

Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
The Y Chromosome Determines Maleness02:19

The Y Chromosome Determines Maleness

The Y chromosome is a sex chromosome found in several vertebrates and mammals, including humans. In addition to 22 pairs of autosomes, the human males have one X chromosome and one Y chromosome. In these organisms, the presence or absence of the Y chromosome determines the development of male traits.
Evolution
Around 300 million years ago, the two sex chromosomes diverged from two identical autosomal chromosomes. Over time, the Y chromosome has lost most of its genes, shrinking in size. Today,...
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...